161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
HIV-1 protein suppresses immune response more broadly than thought

HIV-1 protein suppresses immune response more broadly than thought

by eLifeHIV-1 Virus. Credit: J Roberto Trujillo/WikipediaScientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection

HIV-1 protein suppresses immune response more broadly than thought

by eLifeHIV-1 Virus. Credit: J Roberto Trujillo/WikipediaScientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection
New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon
Study explores characteristics associated with poor COVID-19 antibody response

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l
How does SARS-CoV-2 evade our immune defenses?

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA
Discovery identifies those likely to experience life-threatening dengue fever

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio
MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo
First-in-human vaccine trial for deadly Nipah virus launched

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t

First-in-human vaccine trial for deadly Nipah virus launched

JANUARY 11, 2024byUniversity of OxfordCredit: CC0 Public DomainThe University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.This is t
COVID-19 vaccine responses to be studied in people with immune deficits

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe
'Self-sabotage' prevents immune protection against malaria

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse
New study highlights COVID-19's adaptive strategy for infection

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain
COVID-19 vaccination shown to protect people with blood cancer

COVID-19 vaccination shown to protect people with blood cancer

by Ludwig Maximilian University of MunichStudy time chart, anti-spike IgG levels and IgG avidity in individuals with hematologic neoplasia and in healthy individuals at different time points afte

COVID-19 vaccination shown to protect people with blood cancer

by Ludwig Maximilian University of MunichStudy time chart, anti-spike IgG levels and IgG avidity in individuals with hematologic neoplasia and in healthy individuals at different time points afte
Study finds COVID-19 had greater impact on life expectancy than previously believed

Study finds COVID-19 had greater impact on life expectancy than previously believed

by Institute for Health Metrics and EvaluationCredit: Unsplash/CC0 Public DomainA newstudypublished inThe Lancetreveals never-before-seen details about staggeringly high m

Study finds COVID-19 had greater impact on life expectancy than previously believed

by Institute for Health Metrics and EvaluationCredit: Unsplash/CC0 Public DomainA newstudypublished inThe Lancetreveals never-before-seen details about staggeringly high m